CAS: 1097917-15-1 - ASP-3026
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
CAS:1097917-15-1
Formula:
C29H40N8O3S
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
580.7447
Ref: AN-AG008TDJ
5mg | 51.00 € | |
10mg | 67.00 € | |
50mg | 175.00 € | |
100mg | 214.00 € |
Estimated delivery in United States, on Friday 24 May 2024
ASP3026
CAS:1097917-15-1
ASP3026 has been used in trials studying the treatment of Solid Tumor, B-Cell Lymphoma, Advanced …
Formula:
C29H40N8O3S
Purity:
98.78%
Color and Shape:
Solid
Molecular weight:
580.74
- Inhibitors
- Angiogenesis
- Apoptosis
- Tyrosine Kinase/Adaptors
- See more categories
- ALK
Ref: TM-T1962
2mg | 41.00 € | |
5mg | 58.00 € | |
10mg | 86.00 € | |
25mg | 129.00 € | |
50mg | 184.00 € | |
100mg | 306.00 € | |
1ml*10 (DMSO) | 119.00 € |
Estimated delivery in United States, on Friday 31 May 2024
ASP3026
CAS:1097917-15-1
ASP3026 is a potent anti-tumor agent that binds to the epidermal growth factor receptor (EGFR) …
Formula:
C29H40N8O3S
Purity:
Min. 95%
Molecular weight:
580.75 g/mol
Ref: 3D-XTB91715
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Friday 5 Jul 2024